Concepedia

Zelig Eshhar

ZE

Statistics

Publications

137

Citations

12.8K

H-Index

55

Active since

1968

Affiliations

Weizmann Institute of Science(Current)

Hebrew University of Jerusalem

Tel Aviv University

American Committee for the Weizmann Institute of Science

Tel Aviv Sourasky Medical Center

Zelig Eshhar is an author at Weizmann Institute of Science specializing in life sciences, immunology, and oncology.

Publications per year

1968–2021

137

Publications

137

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.

Zelig Eshhar, Tova Waks, G. Gross et al. · Proceedings of the National Academy of Sciences · 1993 · 1.6K citations

, , +17

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

G. Gross, Tova Waks, Zelig Eshhar · Proceedings of the National Academy of Sciences · 1989 · 1.6K citations · Full text

, , +17

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker et al. · Clinical Cancer Research · 2006 · 1.2K citations · Full text

, , +17

A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity

Yangbing Zhao, Qiong J. Wang, Shicheng Yang et al. · The Journal of Immunology · 2009 · 294 citations · Full text

, , +17

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.

Patrick Hwu, James C. Yang, R Cowherd et al. · PubMed · 1995 · 275 citations

, , +17

1–5 of 137